Bayer to Sell Diabetes Care to Panasonic Holding

Bayer HealthCare said it has entered a definitive agreement to sell its Diabetes Care business with sales in 2014 of €909 million to Panasonic Healthcare Holdings for €1.02 billion.
Closing of the transaction is expected for the first quarter of 2016, subject to customary conditions, including antitrust clearance.
The sale includes Bayer's portfolio of blood glucose monitoring meters and strips, as well as lancing devices.
US private equity group KKR owns 80% of Panasonic Healthcare Holdings, Panasonic Corporation the remaining 20%.
"We are confident that the sale of our Diabetes Care business to our long-standing partner Panasonic Healthcare, with the strong backing of KKR, will support the long-term sustainability of this portfolio," said Werner Baumann, member of the Board of Management of Bayer AG and CEO of Bayer HealthCare.
KKR called the deal “another milestone” in its track record of partnering with leading German and Japanese corporates and in growing top health care companies.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.